Corporate
Aptevo Therapeutics CEO Marvin White Retires After 9-Year Tenure, COO Lamothe to Take Helm
3d ago
You're signed outSign in or to get full access.
AT
Aptevo Therapeutics (APVO)·Earnings Reports
Q4 2024
View earnings summary and analysis
Q3 2024
View earnings summary and analysis
Q2 2024
View earnings summary and analysis
Q1 2024
View earnings summary and analysis
Research analysts covering Aptevo Therapeutics.